Hold Wockhardt, may hit Rs 1650-1750 in a year: Tater

Aashish Tater of FortuneWizard.com told CNBC-TV18, “Right now we are under review for Wockhardt rating. Last time we suggested that one should be switching from something like Wockhardt to Sun Pharma Advanced Research Company (SPARC) because at that point of time risk reward was not that favourable.”

He further added, “Right now the best strategy would be to wait for a week and let it stabilise. Though our technical team has recommended a buy at Rs 1100, but fundamentally we are still reviewing it. Right now hold on, don’t make the mistake of averaging. Time horizon needs to be at least of one year for the stock to reach Rs 1650-1750 levels, if there is no negative development in the stock.”